Mónica Garzón

463 total citations
6 papers, 263 citations indexed

About

Mónica Garzón is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Mónica Garzón has authored 6 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Mónica Garzón's work include Lung Cancer Treatments and Mutations (6 papers), Cancer Genomics and Diagnostics (4 papers) and Genetic factors in colorectal cancer (3 papers). Mónica Garzón is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Cancer Genomics and Diagnostics (4 papers) and Genetic factors in colorectal cancer (3 papers). Mónica Garzón collaborates with scholars based in Spain, United States and Denmark. Mónica Garzón's co-authors include Santiago Viteri, Miguel Ángel Molina‐Vila, Rafael Rosell, Niki Karachaliou, Cristina Teixidó, Ana Giménez‐Capitán, Daniela Morales-Espinosa, Enriqueta Felip, Núria Jordana‐Ariza and Kirstine Jacobsen and has published in prestigious journals such as Nature Communications, British Journal of Cancer and Clinical Chemistry.

In The Last Decade

Mónica Garzón

6 papers receiving 260 citations

Peers

Mónica Garzón

MB

PRM

CR

ONCOL

PFM

Aurélie Swalduz France

S. Gadgeel United States

Andrea E. Doak United States

Marta Román Spain

Ilianna Zoi Greece

Chunfang Hao China

Amaya Gascó Spain

Kiyoko Kataoka Japan

Xue-Rui Ye China

Kate Lynn J. Bill United States

Aurélie Swalduz France

Mónica Garzón

126 ×0.8

MB

200 ×1.3

PRM

92 ×0.8

CR

182 ×1.7

ONCOL

34 ×0.7

PFM

Citations per year, relative to Mónica Garzón Mónica Garzón (= 1×) peers Aurélie Swalduz

Countries citing papers authored by Mónica Garzón

Since Specialization

Citations

This map shows the geographic impact of Mónica Garzón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mónica Garzón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mónica Garzón more than expected).

Fields of papers citing papers by Mónica Garzón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mónica Garzón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mónica Garzón. The network helps show where Mónica Garzón may publish in the future.

Co-authorship network of co-authors of Mónica Garzón

This figure shows the co-authorship network connecting the top 25 collaborators of Mónica Garzón. A scholar is included among the top collaborators of Mónica Garzón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mónica Garzón. Mónica Garzón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Giménez‐Capitán, Ana, Jillian Wilhelmina Paulina Bracht, Juan José García, et al.. (2020). Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform. Clinical Chemistry. 67(3). 554–563. 15 indexed citations

2.

Reyes, Roxana, Clara Mayo‐de‐las‐Casas, Cristina Teixidó, et al.. (2019). Clinical Benefit From BRAF/MEK Inhibition in a Double Non-V600E BRAF Mutant Lung Adenocarcinoma: A Case Report. Clinical Lung Cancer. 20(3). e219–e223. 15 indexed citations

3.

Jacobsen, Kirstine, Jordi Bertrán-Alamillo, Miguel Ángel Molina‐Vila, et al.. (2017). Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer. Nature Communications. 8(1). 410–410. 118 indexed citations

4.

Malapelle, Umberto, Danilo Rocco, Mónica Garzón, et al.. (2017). Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients. British Journal of Cancer. 116(6). 802–810. 95 indexed citations

5.

Garzón, Mónica, Sergi Villatoro, Cristina Teixidó, et al.. (2016). KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients. Translational Lung Cancer Research. 5(5). 511–516. 16 indexed citations

6.

González‐Cao, María, Santiago Viteri, Mónica Garzón, et al.. (2016). Usefulness of circulating free DNA for monitoring epidermal growth factor receptor mutations in advanced non-small cell lung cancer patients: a case report. Translational Lung Cancer Research. 5(5). 532–537. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact